62 related articles for article (PubMed ID: 10066385)
1. Pathogenesis of polyglutamine-induced disease: A model for SCA1.
Klement IA; Zoghbi HY; Orr HT
Mol Genet Metab; 1999 Mar; 66(3):172-8. PubMed ID: 10066385
[TBL] [Abstract][Full Text] [Related]
2. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Cummings CJ; Orr HT; Zoghbi HY
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
[TBL] [Abstract][Full Text] [Related]
3. CAG repeat disorder models and human neuropathology: similarities and differences.
Yamada M; Sato T; Tsuji S; Takahashi H
Acta Neuropathol; 2008 Jan; 115(1):71-86. PubMed ID: 17786457
[TBL] [Abstract][Full Text] [Related]
4. The ins and outs of a polyglutamine neurodegenerative disease: spinocerebellar ataxia type 1 (SCA1).
Orr HT
Neurobiol Dis; 2000 Jun; 7(3):129-34. PubMed ID: 10860780
[TBL] [Abstract][Full Text] [Related]
5. The effect of CAT trinucleotide interruptions on the age at onset of spinocerebellar ataxia type 1 (SCA1).
Matsuyama Z; Izumi Y; Kameyama M; Kawakami H; Nakamura S
J Med Genet; 1999 Jul; 36(7):546-8. PubMed ID: 10424816
[TBL] [Abstract][Full Text] [Related]
6. [The advances in research on phosphorylation of polyglutamine disease].
Zhou YF; Jiang H; Tang JG; Tang BS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):414-7. PubMed ID: 18683139
[TBL] [Abstract][Full Text] [Related]
7. [Clinico-genetic study of type I spinocerebelllar ataxia].
Svetel M; Culjković B; Sternić N; Dragasević B; Stojković I; Romac S; Kostić VS
Srp Arh Celok Lek; 1999; 127(5-6):157-62. PubMed ID: 10500422
[TBL] [Abstract][Full Text] [Related]
8. [Autosomal dominant spinocerebellar ataxia].
Legros B; Manto MU
Rev Med Brux; 1999 Dec; 20(6):495-503. PubMed ID: 10672773
[TBL] [Abstract][Full Text] [Related]
9. Cerebellar allografts survive and transiently alleviate ataxia in a transgenic model of spinocerebellar ataxia type-1.
Kaemmerer WF; Low WC
Exp Neurol; 1999 Aug; 158(2):301-11. PubMed ID: 10415138
[TBL] [Abstract][Full Text] [Related]
10. [Candidate gene approach for polyglutamine disease: isolation and characterization of human brain cDNAs containing CAG repeats].
Igarashi S; Amaya N; Tsuji S
Tanpakushitsu Kakusan Koso; 2001 Dec; 46(16 Suppl):2295-8. PubMed ID: 11802382
[No Abstract] [Full Text] [Related]
11. Toward understanding polyglutamine-induced neurological disease in spinocerebellar ataxia type 1.
Orr HT; Zoghbi HY
Cold Spring Harb Symp Quant Biol; 1996; 61():649-57. PubMed ID: 9246491
[No Abstract] [Full Text] [Related]
12. [Molecular biology of polyglutamine diseases].
Owecki M; Kozubski W
Postepy Hig Med Dosw; 2002; 56(6):779-88. PubMed ID: 12661407
[TBL] [Abstract][Full Text] [Related]
13. A SCA7 CAG/CTG repeat expansion is stable in Drosophila melanogaster despite modulation of genomic context and gene dosage.
Jackson SM; Whitworth AJ; Greene JC; Libby RT; Baccam SL; Pallanck LJ; La Spada AR
Gene; 2005 Feb; 347(1):35-41. PubMed ID: 15715978
[TBL] [Abstract][Full Text] [Related]
14. Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease.
Hannan AJ
Acta Biochim Pol; 2004; 51(2):415-30. PubMed ID: 15218539
[TBL] [Abstract][Full Text] [Related]
15. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.
Xia H; Mao Q; Eliason SL; Harper SQ; Martins IH; Orr HT; Paulson HL; Yang L; Kotin RM; Davidson BL
Nat Med; 2004 Aug; 10(8):816-20. PubMed ID: 15235598
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human.
Huynh DP; Figueroa K; Hoang N; Pulst SM
Nat Genet; 2000 Sep; 26(1):44-50. PubMed ID: 10973246
[TBL] [Abstract][Full Text] [Related]
17. Reduction of Purkinje cell pathology in SCA1 transgenic mice by p53 deletion.
Shahbazian MD; Orr HT; Zoghbi HY
Neurobiol Dis; 2001 Dec; 8(6):974-81. PubMed ID: 11741393
[TBL] [Abstract][Full Text] [Related]
18. Enhanced SUMOylation in polyglutamine diseases.
Ueda H; Goto J; Hashida H; Lin X; Oyanagi K; Kawano H; Zoghbi HY; Kanazawa I; Okazawa H
Biochem Biophys Res Commun; 2002 Apr; 293(1):307-13. PubMed ID: 12054600
[TBL] [Abstract][Full Text] [Related]
19. Regional differences of somatic CAG repeat instability do not account for selective neuronal vulnerability in a knock-in mouse model of SCA1.
Watase K; Venken KJ; Sun Y; Orr HT; Zoghbi HY
Hum Mol Genet; 2003 Nov; 12(21):2789-95. PubMed ID: 12952864
[TBL] [Abstract][Full Text] [Related]
20. Identification of genes that modify ataxin-1-induced neurodegeneration.
Fernandez-Funez P; Nino-Rosales ML; de Gouyon B; She WC; Luchak JM; Martinez P; Turiegano E; Benito J; Capovilla M; Skinner PJ; McCall A; Canal I; Orr HT; Zoghbi HY; Botas J
Nature; 2000 Nov; 408(6808):101-6. PubMed ID: 11081516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
